BioGend Therapeutics Co., Ltd. Company Information
BioGend Therapeutics Co., Ltd.'s employee growth, exchange listings and data sources
Key Information
- Name: BioGend Therapeutics Co., Ltd.
- Ticker: 6733
- Exchange: TPEX
- Founded: 2016
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: NT$4.510b
- Shares Outstanding: 124.26m
- Website: https://www.biogend.com
Number of Employees
Location
- BioGend Therapeutics Co., Ltd.
- No.3-2, Park Street
- 4th Floor
- Taipei
- 115
- Taiwan
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 6733 | TPEX (Taipei Exchange) | Yes | Common Shares | TW | TWD | Jun 2019 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/22 13:13 |
| End of Day Share Price | 2024/11/22 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.